X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-01 | IONS | Hayden Michael R | Dir | P - Purchase | $31.86 | +15,000 | 52,219 | +40% | +$477,900 | ||||||
| D | 2025-04-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $28.37 | -680 | 56,660 | -1% | -$19,292 | |||||
| D | 2025-04-16 | IONS | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $28.36 | -3,016 | 11,199 | -21% | -$85,534 | |||||
| D | 2025-04-16 | IONS | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $28.40 | -3,928 | 34,997 | -10% | -$111,555 | |||||
2025-03-11 | IONS | Monia Brett P | CEO | S - Sale | $32.32 | -140 | 180,980 | 0% | -$4,525 | ||||||
2025-02-20 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $32.35 | -1,207 | 56,245 | -2% | -$39,046 | ||||||
2025-02-04 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $31.62 | -6,165 | 57,452 | -10% | -$194,939 | ||||||
2025-02-04 | IONS | Monia Brett P | CEO | S - Sale | $31.65 | -38,843 | 180,683 | -18% | -$1,229,463 | ||||||
2025-01-31 | IONS | Swayze Eric | EVP Research | S - Sale | $32.31 | -1,367 | 48,201 | -3% | -$44,162 | ||||||
2025-01-31 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $32.20 | -1,484 | 61,056 | -2% | -$47,780 | ||||||
2025-01-31 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $32.49 | -1,406 | 63,617 | -2% | -$45,685 | ||||||
2025-01-31 | IONS | Monia Brett P | CEO | S - Sale | $32.45 | -13,242 | 219,526 | -6% | -$429,655 | ||||||
2025-01-31 | IONS | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale | $32.44 | -1,523 | 110,500 | -1% | -$49,404 | ||||||
2025-01-31 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale | $32.40 | -1,406 | 99,077 | -1% | -$45,561 | ||||||
2025-01-31 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $32.46 | -1,327 | 93,146 | -1% | -$43,079 | ||||||
| D | 2025-01-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $32.84 | -7,176 | 45,854 | -14% | -$235,678 | |||||
| D | 2025-01-16 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $32.79 | -6,523 | 58,508 | -10% | -$213,889 | |||||
| D | 2025-01-16 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale+OE | $32.83 | -7,360 | 61,203 | -11% | -$241,629 | |||||
| D | 2025-01-16 | IONS | Monia Brett P | CEO | S - Sale+OE | $32.63 | -33,445 | 207,396 | -14% | -$1,091,444 | |||||
| D | 2025-01-16 | IONS | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale+OE | $32.81 | -8,870 | 107,885 | -8% | -$290,989 | |||||
| D | 2025-01-16 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale+OE | $32.86 | -7,072 | 96,663 | -7% | -$232,407 | |||||
| D | 2025-01-16 | IONS | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale+OE | $32.78 | -4,267 | 15,937 | -21% | -$139,855 | |||||
| D | 2025-01-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $32.70 | -5,400 | 55,051 | -9% | -$176,580 | |||||
| D | 2025-01-16 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $32.90 | -6,752 | 90,866 | -7% | -$222,114 | |||||
| D | 2025-01-16 | IONS | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $32.70 | -4,430 | 28,088 | -14% | -$144,861 | |||||
2024-12-23 | IONS | Hayden Michael R | Dir | P - Purchase | $36.22 | +5,000 | 37,219 | +16% | +$181,079 | ||||||
2024-11-12 | IONS | Swayze Eric | EVP Research | S - Sale | $37.92 | -1,194 | 33,870 | -3% | -$45,278 | ||||||
2024-11-12 | IONS | Monia Brett P | CEO | S - Sale | $38.05 | -6,630 | 167,393 | -4% | -$252,294 | ||||||
2024-11-12 | IONS | Loscalzo Joseph | Dir | S - Sale | $37.86 | -13,508 | 32,251 | -30% | -$511,426 | ||||||
| D | 2024-10-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $38.31 | -53 | 35,064 | 0% | -$2,031 | |||||
| A | 2024-02-02 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale | $50.04 | -1,995 | 87,300 | -2% | -$99,836 | |||||
| A | 2024-02-02 | IONS | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale | $49.54 | -2,162 | 92,868 | -2% | -$107,105 | |||||
| A | 2024-02-02 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $49.67 | -1,995 | 48,627 | -4% | -$99,099 | |||||
| A | 2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,106 | 47,659 | -4% | -$104,437 | |||||
| A | 2024-02-02 | IONS | Swayze Eric | EVP Research | S - Sale | $49.56 | -1,940 | 34,291 | -5% | -$96,149 | |||||
| A | 2024-02-02 | IONS | Monia Brett P | CEO | S - Sale | $49.37 | -23,907 | 173,732 | -12% | -$1,180,348 | |||||
| A | 2024-02-02 | IONS | Monia Brett P | CEO | S - Sale | $49.37 | -23,907 | 173,732 | -12% | -$1,180,348 | |||||
| A | 2024-02-02 | IONS | Cadoret-Manier Onaiza | EVP,Chf GL Pdt Str, Oper Ofc | S - Sale | $49.60 | -2,162 | 35,788 | -6% | -$107,240 | |||||
| A | 2024-02-02 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $49.52 | -1,885 | 79,047 | -2% | -$93,337 | |||||
| M | 2024-08-28 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale | $49.40 | -651 | 84,823 | -1% | -$32,159 | |||||
2024-08-05 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale | $48.00 | -2,430 | 85,508 | -3% | -$116,640 | ||||||
| D | 2024-07-16 | IONS | Klein Joseph III | Dir | S - Sale+OE | $50.00 | -12,000 | 16,446 | -42% | -$600,000 | |||||
| D | 2024-07-16 | IONS | Diaz Allene M. | Dir | S - Sale+OE | $49.49 | -1,637 | 15,716 | -9% | -$81,019 | |||||
| D | 2024-06-17 | IONS | Berthelsen Spencer R | Dir | S - Sale+OE | $40.29 | -16,000 | 147,327 | -10% | -$644,640 | |||||
2024-05-03 | IONS | Klein Joseph III | Dir | S - Sale | $42.71 | -6,000 | 16,446 | -27% | -$256,277 | ||||||
| D | 2024-04-16 | IONS | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $41.60 | -4,006 | 21,271 | -16% | -$166,641 | |||||
| D | 2024-04-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $41.66 | -905 | 46,156 | -2% | -$37,698 | |||||
2024-02-16 | IONS | Monia Brett P | CEO | S - Sale | $44.49 | -387 | 173,751 | 0% | -$17,219 | ||||||
| M | 2024-01-31 | IONS | Swayze Eric | EVP Research | S - Sale | $51.63 | -12,680 | 34,409 | -27% | -$654,709 | |||||
2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,071 | 49,812 | -4% | -$102,701 | ||||||
2024-02-02 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $49.67 | -1,961 | 48,661 | -4% | -$97,410 | ||||||
2024-02-02 | IONS | Monia Brett P | CEO | S - Sale | $49.37 | -23,501 | 174,138 | -12% | -$1,160,303 | ||||||
2024-02-02 | IONS | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale | $49.54 | -2,125 | 92,905 | -2% | -$105,272 | ||||||
2024-02-02 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale | $50.04 | -1,961 | 87,334 | -2% | -$98,135 | ||||||
2024-02-02 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | S - Sale | $49.60 | -2,125 | 35,825 | -6% | -$105,404 | ||||||
2024-02-02 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $49.52 | -1,853 | 79,079 | -2% | -$91,752 | ||||||
2024-01-25 | IONS | Monia Brett P | CEO | S - Sale | $51.75 | -2,285 | 151,851 | -1% | -$118,249 | ||||||
2024-01-25 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $51.75 | -6,450 | 46,802 | -12% | -$333,788 | ||||||
| D | 2024-01-17 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | S - Sale+OE | $50.42 | -5,564 | 33,810 | -14% | -$280,520 | |||||
| D | 2024-01-17 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale+OE | $50.42 | -7,744 | 53,252 | -13% | -$390,429 | |||||
| D | 2024-01-17 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $50.42 | -4,497 | 44,582 | -9% | -$226,725 | |||||
| D | 2024-01-17 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $50.42 | -6,305 | 43,374 | -13% | -$317,879 | |||||
| D | 2024-01-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $50.42 | -5,482 | 47,850 | -10% | -$276,386 | |||||
| D | 2024-01-17 | IONS | Monia Brett P | CEO | S - Sale+OE | $50.42 | -32,059 | 154,136 | -17% | -$1,616,319 | |||||
| D | 2024-01-17 | IONS | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale+OE | $50.42 | -8,683 | 90,890 | -9% | -$437,771 | |||||
| D | 2024-01-17 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale+OE | $50.42 | -7,338 | 85,475 | -8% | -$369,960 | |||||
| D | 2024-01-17 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $50.42 | -6,745 | 77,323 | -8% | -$340,063 | |||||
| D | 2024-01-17 | IONS | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $50.42 | -2,024 | 14,439 | -12% | -$102,044 | |||||
| D | 2024-01-12 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $53.50 | -8,000 | 38,170 | -17% | -$427,999 | |||||
| D | 2023-12-28 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $50.19 | -27,100 | 32,589 | -45% | -$1,360,081 | |||||
| D | 2023-12-26 | IONS | O'Neil Patrick R. | EVP CLO, GC | S - Sale+OE | $51.46 | -20,825 | 40,355 | -34% | -$1,071,717 | |||||
| DM | 2023-12-26 | IONS | Parshall B Lynne | Dir | S - Sale+OE | $50.48 | -117,638 | 82,588 | -59% | -$5,938,129 | |||||
| D | 2023-12-26 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $51.46 | -25,000 | 36,052 | -41% | -$1,286,575 | |||||
| DM | 2023-12-20 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $49.39 | -22,613 | 65,754 | -26% | -$1,116,854 | |||||
| DM | 2023-12-20 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale+OE | $49.50 | -10,612 | 72,961 | -13% | -$525,324 | |||||
| DM | 2023-12-20 | IONS | Monia Brett P | CEO | S - Sale+OE | $49.38 | -24,000 | 118,111 | -17% | -$1,185,220 | |||||
| D | 2023-12-14 | IONS | Monia Brett P | CEO | S - Sale+OE | $49.58 | -24,000 | 118,111 | -17% | -$1,190,019 | |||||
| D | 2023-12-14 | IONS | Geary Richard S | EVP, Chief Development Officer | S - Sale+OE | $49.58 | -10,613 | 72,961 | -13% | -$526,236 | |||||
| D | 2023-12-14 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $49.58 | -22,612 | 65,754 | -26% | -$1,121,195 | |||||
2023-11-15 | IONS | Klein Joseph III | Dir | S - Sale | $50.00 | -2,000 | 22,446 | -8% | -$100,000 | ||||||
| D | 2023-10-17 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $47.95 | -52 | 32,589 | 0% | -$2,493 | |||||
2023-10-12 | IONS | Monia Brett P | CEO | S - Sale | $46.00 | -3,770 | 118,111 | -3% | -$173,420 | ||||||
2023-09-28 | IONS | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $46.50 | -4,460 | 65,754 | -6% | -$207,390 | ||||||
2023-09-26 | IONS | Parshall B Lynne | Dir | S - Sale | $45.13 | -10,000 | 82,588 | -11% | -$451,268 | ||||||
2023-09-26 | IONS | Klein Joseph III | Dir | S - Sale | $45.13 | -2,000 | 24,446 | -8% | -$90,254 | ||||||
2023-08-01 | IONS | Diaz Allene M. | Dir | S - Sale | $41.05 | -657 | 12,676 | -5% | -$26,970 | ||||||
| D | 2023-07-18 | IONS | Klein Joseph III | Dir | S - Sale+OE | $42.00 | -3,555 | 26,446 | -12% | -$149,310 | |||||
2023-07-07 | IONS | Monia Brett P | CEO | S - Sale | $42.25 | -18,650 | 121,724 | -13% | -$787,953 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |